SEngine Precision Medicine Company

SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.

Total Funding: 21200000.0
Headquarters: Seattle, Washington, United States
Funding Status: Early Stage Venture
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Last Funding Type: Series A
Technology: Biotechnology
Last Funding Date: 2022-07-28
Investors Number: 5.0
Founded Date: 2015-01-01
Industry: Early Drug Development